Global Non-invasive Prenatal Testing Market
Healthcare Services

Global Non-invasive Prenatal Testing Market Outlook, Opportunities And Strategies

Learn about the global non-invasive prenatal testing market through The Business Research Company, which provides information on non-invasive prenatal testing market size, non-invasive prenatal testing market drivers and restraints, non-invasive prenatal testing market players, the COVID-19 impact on the non-invasive prenatal testing market, and more.

 

The global non-invasive prenatal testing market size is expected to grow from $3.67 billion in 2021 to $4.21 billion in 2022 at a compound annual growth rate (CAGR) of 14.8%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The non-invasive prenatal testing market is expected to reach $7.34 billion in 2026 at a CAGR of 14.9%.

The increased risk of having babies with Down syndrome among older women drives the non-invasive prenatal testing market.

 

Request A Sample For The Global Non-invasive Prenatal Testing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2492&type=smph

 

The non-invasive prenatal testing market consists of sales of non-invasive prenatal testing kits, instruments and related services. Non-invasive prenatal testing kits and equipment are used to diagnose genetic abnormalities, mainly chromosome defects in foetus in first trimester of pregnancy. Non-invasive prenatal testing includes ultrasound detection, foetal cells in maternal blood tests, cell-free DNA in maternal plasma tests and biochemical screening tests.

 

Global Non-Invasive Prenatal Testing Market Segments Include:

By Type: Consumables, Instruments

By End User: Hospital, Diagnostic Labs

By Instruments: NGS Systems, PCR Instruments, Microarrays, Ultrasound Devices, Others (Centrifuges, UV Systems, Incubators, Microscopes)

By Consumables: Assay Kits & Reagents, Disposables

By Application: Trisomy, Microdeletion, Genetics, Rh Factor

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

 

Next generation sequencing has increased the throughput, scalability, and speed, and further enables researchers to perform a wide range of applications and study biological systems at a higher level. Next generation sequencing is a platform that has enabled sequencing of thousands to millions of DNA molecules simultaneously. The manufacturers have introduced this technology to reduce the time and money required and optimizes the output to generate results regarding genome, DNA testing.

 

TBRC’s non-invasive prenatal testing market report covers:

Major Market Players: F F. Hoffmann-La Roche AG, IlluminaInc., Laboratory Corporation of America Holdings, NateraInc., PerkinElmerInc., Quest Diagnostics Incorporated, Agilent TechnologiesInc, BGI Diagnosis, Berry Genomics Co., Ltd, LifeCodexx AG, Myriad GeneticsInc., NIPD Genetics, SequenomInc., Annoroad Gene Technology, Centogene AG, CounsylInc., EUROFINS Genoma Group, Eurofins Scientific, Next Biosciences, Premaitha Health Plc, Ariosa Diagnostics (Roche), Premaitha Health, Beijing Genomics Institute, Yourgene Health PLC, GE Healthcare, Koninklijke Philips N.V., Thermo Fisher ScientificInc., Pacific Biosciences of CaliforniaInc., and QIAGEN N.V.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2016-21) and ten years forecast (2022-2026-2031)

 

The Non-Invasive Prenatal Testing Global Market Report 2022–Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides non-invasive prenatal testing market overviews, analyzes and forecasts market size, share, non-invasive prenatal testing market players, non-invasive prenatal testing market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s non-invasive prenatal testing market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

 

Here Is A List Of Similar Reports From The Business Research Company:

Fertility Services Global Market Report 2022

Prenatal Testing & Newborn Screening Global Market Report 2022

Healthcare Services Global Market Report 2022

 

Interested To Know More About The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

 

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

 

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Leave a Reply

Your email address will not be published. Required fields are marked *